• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞和批量RNA测序揭示前列腺癌的肿瘤内异质性和恶性进展机制

Single-Cell and Bulk RNA Sequencing Highlights Intra-Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer.

作者信息

Wu Junchao, Chen Ziqi, Wu Wentian, Qin Jiaxuan, Zhong Rongfang, Meng Jialin, Yin Yu, Guo Peng, Fan Song

机构信息

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Institute of Urology, Anhui Medical University, Hefei, China.

出版信息

J Cell Mol Med. 2025 Aug;29(16):e70806. doi: 10.1111/jcmm.70806.

DOI:10.1111/jcmm.70806
PMID:40857024
Abstract

Prostate cancer (PCa) is an extremely heterogeneous cancer and is highly prevalent in the older male population. Since intra-tumour heterogeneity (ITH) commonly results in PCa chemotherapy resistance and recurrence, it is critical to explore its effects on tumour behaviour. Prognostic genes related to ITH were identified, and a signature was constructed using Cox regression analyses and multiple machine learning algorithms. Single-cell RNA sequencing data extracted from PCa and CRPC samples were analysed via sub-clustering, pseudotime, cell communication and drug sensitivity approaches to elucidate their function. The oncogenic potential of hub genes was confirmed by immunohistochemistry and cell proliferation assays. An 11-gene signature underlying a prostate cancer meta-program (PCMP) was generated by selecting an optimal combination of machine learning methods. Survival assays and multivariate Cox regression analyses conducted in multiple cohorts revealed the superior prognostic value of the PCMP signature. Functional enrichment analyses indicated that it dysregulates the cell cycle. Using trajectory and cell-cell communication analyses, we illustrated that PCMP genes exert oncogenic effects by enhancing the proliferation and oxidative phosphorylation of epithelial cells. Intra-cellular assays also demonstrated that CENPA and CKS1B had promising malignant potential. In summary, our research not only establishes the association between the PCMP signature and reveals its malignant characteristics, but also deepens our understanding of the mechanisms underlying PCa progression and ITH. It holds promise for the development of targeted therapeutic interventions, thereby offering clinical benefits to patients.

摘要

前列腺癌(PCa)是一种极具异质性的癌症,在老年男性群体中高度流行。由于肿瘤内异质性(ITH)通常会导致PCa化疗耐药和复发,因此探索其对肿瘤行为的影响至关重要。我们鉴定了与ITH相关的预后基因,并使用Cox回归分析和多种机器学习算法构建了一个特征标签。通过亚聚类、伪时间、细胞通讯和药物敏感性分析方法,对从PCa和CRPC样本中提取的单细胞RNA测序数据进行分析,以阐明其功能。通过免疫组织化学和细胞增殖试验证实了枢纽基因的致癌潜力。通过选择机器学习方法的最佳组合,生成了一个基于前列腺癌元程序(PCMP)的11基因特征标签。在多个队列中进行的生存分析和多变量Cox回归分析显示,PCMP特征标签具有卓越的预后价值。功能富集分析表明,它会失调细胞周期。通过轨迹和细胞间通讯分析,我们阐明了PCMP基因通过增强上皮细胞的增殖和氧化磷酸化发挥致癌作用。细胞内试验还表明,CENPA和CKS1B具有潜在的恶性潜能。总之,我们的研究不仅建立了PCMP特征标签之间的关联并揭示了其恶性特征,还加深了我们对PCa进展和ITH潜在机制的理解。它为开发靶向治疗干预措施带来了希望,从而为患者提供临床益处。

相似文献

1
Single-Cell and Bulk RNA Sequencing Highlights Intra-Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer.单细胞和批量RNA测序揭示前列腺癌的肿瘤内异质性和恶性进展机制
J Cell Mol Med. 2025 Aug;29(16):e70806. doi: 10.1111/jcmm.70806.
2
Integration of single-cell and bulk RNA-sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer.单细胞和批量RNA测序数据的整合揭示了上皮基因标志物对前列腺癌的预后潜力。
Mol Oncol. 2025 Jun;19(6):1811-1835. doi: 10.1002/1878-0261.13804. Epub 2025 Feb 19.
3
Joint analysis of single-cell RNA sequencing and bulk transcriptome reveals the heterogeneity of the urea cycle of astrocytes in glioblastoma.单细胞RNA测序与批量转录组联合分析揭示胶质母细胞瘤中星形胶质细胞尿素循环的异质性
Neurobiol Dis. 2025 May;208:106835. doi: 10.1016/j.nbd.2025.106835. Epub 2025 Feb 10.
4
Comprehensive single-cell transcriptomic analysis reveals fibroblast subpopulations and the prognostic association of COMT in prostate cancer progression, COMT , COMT.全面的单细胞转录组分析揭示了成纤维细胞亚群以及儿茶酚-O-甲基转移酶(COMT)在前列腺癌进展中的预后关联,儿茶酚-O-甲基转移酶(COMT),儿茶酚-O-甲基转移酶(COMT) 。 (注:原文中COMT重复出现,不太符合正常表述逻辑,翻译时保留了原文形式)
Sci Rep. 2025 Jul 28;15(1):27467. doi: 10.1038/s41598-025-10624-8.
5
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer.一种抗雄激素抵抗相关基因特征作为一种预后标志物,并通过抑制PLK1增加恩杂鲁胺在前列腺癌中的疗效。
J Transl Med. 2025 Apr 27;23(1):480. doi: 10.1186/s12967-025-06457-8.
6
Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.基于单细胞和 bulk RNA 测序的前列腺癌中与癌症相关成纤维细胞相关亚型的鉴定和验证,以及生化复发的预后模型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11379-11395. doi: 10.1007/s00432-023-05011-7. Epub 2023 Jun 28.
7
Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC.基于单细胞和批量RNA测序的细胞层级框架揭示脂肪酸代谢生物标志物MYDGF作为ccRCC的治疗靶点。
Front Immunol. 2025 Jun 5;16:1615601. doi: 10.3389/fimmu.2025.1615601. eCollection 2025.
8
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
9
Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches.利用机器学习方法鉴定与转移相关的基因,用于预测前列腺癌的诊断、转移和免疫治疗药物靶标。
Biol Direct. 2024 Jun 25;19(1):50. doi: 10.1186/s13062-024-00494-x.
10
Single cell RNA sequencing to identify an Immunogenic cell death related prognostic signature in intrahepatic cholangiocarcinoma.单细胞RNA测序以鉴定肝内胆管癌中与免疫原性细胞死亡相关的预后特征。
Sci Rep. 2025 Jul 2;15(1):23501. doi: 10.1038/s41598-025-08602-1.

本文引用的文献

1
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer.单细胞和整体转录组的综合分析揭示了人类前列腺癌中与临床相关的分子亚型。
Chin J Cancer Res. 2025 Jan 30;37(1):90-114. doi: 10.21147/j.issn.1000-9604.2025.01.07.
2
Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression.整合单细胞转录组分析鉴定出一种新型与谱系可塑性相关的癌症细胞类型,该细胞类型与前列腺癌进展有关。
EBioMedicine. 2024 Nov;109:105398. doi: 10.1016/j.ebiom.2024.105398. Epub 2024 Oct 16.
3
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review.
转移性去势抵抗性前列腺癌的强化治疗方法与治疗顺序:一项系统综述
Eur Urol. 2025 Jan;87(1):29-46. doi: 10.1016/j.eururo.2024.09.008. Epub 2024 Sep 20.
4
PSA Screening and Prostate Cancer Mortality.前列腺特异性抗原(PSA)筛查与前列腺癌死亡率
JAMA. 2024 Sep 10;332(10):842-843. doi: 10.1001/jama.2024.13803.
5
Advances in and prospects of immunotherapy for prostate cancer.前列腺癌免疫治疗的进展与展望。
Cancer Lett. 2024 Oct 1;601:217155. doi: 10.1016/j.canlet.2024.217155. Epub 2024 Aug 8.
6
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.单细胞分析治疗抵抗性前列腺癌:细胞状态变化对细胞表面抗原靶向治疗的影响。
Proc Natl Acad Sci U S A. 2024 Jul 9;121(28):e2322203121. doi: 10.1073/pnas.2322203121. Epub 2024 Jul 5.
7
Complex heatmap visualization.复杂热图可视化。
Imeta. 2022 Aug 1;1(3):e43. doi: 10.1002/imt2.43. eCollection 2022 Sep.
8
One-Class SVM Probabilistic Outputs.单类支持向量机概率输出。
IEEE Trans Neural Netw Learn Syst. 2025 Apr;36(4):6244-6256. doi: 10.1109/TNNLS.2024.3395148. Epub 2025 Apr 4.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer.YTHDC1 依赖性 m6A 修饰调节 FOXM1 通过 CENPA 促进三阴性乳腺癌中的糖酵解和肿瘤进展。
Cancer Sci. 2024 Jun;115(6):1881-1895. doi: 10.1111/cas.16137. Epub 2024 Apr 3.